Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
Clinical trial NCT02033941 · TERMINATED
Trial details
- NCT number
- NCT02033941
- Sponsor
- Hillel Grossman
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-03
- Primary completion
- 2019-10-04
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.